venBio Partners
Latest statistics and disclosures from venBio Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PHVS, Parabilis Medicines, ALMS, ACHV, ALXO, and represent 95.78% of venBio Partners's stock portfolio.
- Added to shares of these 3 stocks: Parabilis Medicines (+$144M), ACHV (+$39M), PHVS.
- Started 2 new stock positions in ACHV, Parabilis Medicines.
- Reduced shares in these 2 stocks: ARTV, HRMY.
- Sold out of its position in ARTV.
- venBio Partners was a net buyer of stock by $179M.
- venBio Partners has $519M in assets under management (AUM), dropping by 85.13%.
- Central Index Key (CIK): 0001776382
Tip: Access up to 7 years of quarterly data
Positions held by venBio Partners consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for venBio Partners
venBio Partners holds 7 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 30.9 | $161M | 4.6M | 34.58 |
|
|
| Parabilis Medicines | 27.8 | $144M | NEW | 5.3M | 27.37 |
|
| Alumis (ALMS) | 24.5 | $127M | 4.5M | 28.14 |
|
|
| Achieve Life Sciences (ACHV) | 7.4 | $39M | NEW | 5.9M | 6.53 |
|
| Alx Oncology Hldgs (ALXO) | 5.1 | $27M | 13M | 2.07 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 3.3 | $17M | -3% | 472k | 36.41 |
|
| Lyell Immunopharma Com New (LYEL) | 0.9 | $4.7M | 338k | 14.05 |
|
Past Filings by venBio Partners
SEC 13F filings are viewable for venBio Partners going back to 2019
- venBio Partners 2026 Q2 filed Aug. 14, 2026
- venBio Partners 2026 Q1 filed May 15, 2026
- venBio Partners 2025 Q4 filed Feb. 17, 2026
- venBio Partners 2025 Q3 filed Nov. 14, 2025
- venBio Partners 2025 Q2 filed Aug. 14, 2025
- venBio Partners 2025 Q1 filed May 15, 2025
- venBio Partners 2024 Q4 filed Feb. 14, 2025
- venBio Partners 2024 Q3 filed Nov. 14, 2024
- venBio Partners 2024 Q2 filed Aug. 14, 2024
- venBio Partners 2024 Q1 filed May 15, 2024
- venBio Partners 2023 Q4 filed Feb. 14, 2024
- venBio Partners 2023 Q3 filed Nov. 14, 2023
- venBio Partners 2023 Q2 filed Aug. 14, 2023
- venBio Partners 2023 Q1 filed May 15, 2023
- venBio Partners 2022 Q4 filed Feb. 14, 2023
- venBio Partners 2022 Q3 filed Nov. 14, 2022